SYNKRINO BIOTHERAPEUTICS

synkrino-biotherapeutics-logo

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric rheumatologists for life-threatening conditions. It is currently building a rapid, portable field test for the RNA virus 2019-nCoV/COVID-19, adapting its existing analytic protocols for community public health screening. Synkrino Biotherapeutics' therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.

#SimilarOrganizations #People #Financial #Website #More

SYNKRINO BIOTHERAPEUTICS

Industry:
Artificial Intelligence (AI) Biotechnology Health Care Therapeutics

Founded:
2018-01-01

Address:
Berkeley, California, United States

Country:
United States

Website Url:
http://www.synkrino.bio

Total Employee:
1+

Status:
Active

Technology used in webpage:
Amazon Google Apps For Business Cloudflare DNS AWS Global Accelerator Webflow


Similar Organizations

activeo-logo

ActiveO

ActiveO, a spine technology company, develops and delivers image-guided therapies to treat back pain.

ibis-therapeutics-logo

IBIS Therapeutics

IBIS Therapeutics is accelerating drug discovery through Molecular Fingerprintโ„ข Platform

na-genomics-logo

N.A. Genomics

N.A. Genomics is a Personal Health AI Platform that helps to optimize health based on DNA information and other characteristics.

nivalis-therapeutics-logo

Nivalis Therapeutics

Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.

transaxon-logo

TransAxon

Reality-level Brain Computer Interfaces

Current Employees Featured

not_available_image

Jason Barbour
Jason Barbour Co-Founder and CEO @ Synkrino Biotherapeutics
Co-Founder and CEO

not_available_image

David Ott
David Ott CTO and Co-Founder @ Synkrino Biotherapeutics
CTO and Co-Founder

Founder


not_available_image

David Ott

not_available_image

Jason Barbour

Investors List

endpoint-ventures_image

Endpoint Ventures

Endpoint Ventures investment in Seed Round - Synkrino Biotherapeutics

y-combinator_image

Y Combinator

Y Combinator investment in Seed Round - Synkrino Biotherapeutics

Official Site Inspections

http://www.synkrino.bio

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Synkrino Biotherapeutics"

Synkrino Biotherapeutics - Crunchbase Company Profile & Funding

Synkrino Biotherapeutics' therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers โ€ฆSee details»

Synkrino Biotherapeutics - PitchBook

Www.synkrino.bio. Ownership Status. Out of Business. Financing Status. Formerly VC-backed. Corporate Office. 1111 Broadway; Oakland, CA 94607; United States; Primary Industry. ... Synkrino Biotherapeuticsโ€™s primary industry โ€ฆSee details»

Synkrino Biotherapeutics - Y Combinator

Synkrino's AI, SATIS is a powerful, unbiased discovery system forโ€ฆ. Founded in by Jason Barbour and David Ott, Synkrino Biotherapeutics has 2 employees based in Oakland, CA, USA.See details»

Synkrino Biotherapeutics - VentureRadar

Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system of patients. The AI + Immunology Discovery Engine has identified two novel drug โ€ฆSee details»

Synkrino Biotherapeutics - The Org

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric โ€ฆSee details»

Synkrino Biotherapeutics, Inc. - Company Profile - Corporation Wiki

Jun 14, 2018 Synkrino Biotherapeutics, Inc. Overview. Synkrino Biotherapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Thursday, June โ€ฆSee details»

Synkrino Biotherapeutics - LinkedIn

Frank Alzaga-Chaudhry Chief Strategy Officer / Chief Business Officer / CEO - Pharma / BiotechSee details»

Synkrino Biotherapeutics - Funding, Financials, Valuation & Investors

Aug 23, 2018 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 23, โ€ฆSee details»

Synkrino Biotherapeutics Company Profile - Office Locations ...

Synkrino Biotherapeutics has 5 employees at their 1 location. See insights on Synkrino Biotherapeutics including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

Synkrino Biotherapeutics - Golden

Synkrino Biotherapeutics is a biotechnology company that offers a platform that works on discovering and developing novel drug targets from the immune system of patients. Synkrino โ€ฆSee details»

Synkrino Biotherapeutics | Company | Mindmaps

Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. Investors Endpoint VenturesSee details»

Synkrino Biotherapeutics - Updates, News, Events, Signals & Triggers

Aug 23, 2018 Organization. Synkrino Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Recent News & Activity. โ€ฆSee details»

Synkrino Biotherapeutics - Products, Competitors, Financials, โ€ฆ

Synkrino Biotherapeutics is a precision medicine analytics platform providing monitoring for pediatric rheumatologists for life-threatening conditions. Synkrino Biotherapeutics is currently โ€ฆSee details»

Synkrino Biotherapeutics - Berkeley Emeryville BIO

Synkrino Biotherapeutics. C/O Citris Foun, UC Berkeley 450 Sutardja Dai Hall. Berkeley. Website. Developer of novel therapeutics designed to treat patients with diseases driven by the immune โ€ฆSee details»

Synkrino Biotherapeutics - Company Information | YCDB - The Y ...

Synkrino Biotherapeutics. Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system... Live. Statistics. Compare to all YC; Compare to S18; โ€ฆSee details»

Value Proposition - SDC

Synkrino Development Company partners with biotech to finance and develop innovative high impact therapeutics programs. We serve the entire pharma ecosystem of patients, prescribers, โ€ฆSee details»

Synkrino Biotherapeutics | CipherBio

Explore Synkrino Biotherapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Synkrino Biotherapeutics - Contacts, Employees, Board Members, โ€ฆ

Organization. Synkrino Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. โ€ฆSee details»

David Ott - Synkrino Biotherapeutics - LinkedIn

David and I developed Synkrino Bio in early 2018, working from offices in the Berkeley School of Engineering, before joining Y Combinator that summer.See details»

Top Synkrino Biotherapeutics Competitors and Alternatives - Craft

Synkrino Biotherapeutics's main competitors include Nucleai, Intelligencia, Formation Bio and Biosortia Microbiomics. Compare Synkrino Biotherapeutics to its competitors by revenue, โ€ฆSee details»

linkstock.net © 2022. All rights reserved